Renee Spends ₹49 to Earn ₹100.

The 30-Second Summary

For every ₹100 Renee earned in FY2025, ₹49 went to ads.

The category is profitable. The company isn't.

Revenue grew 63%. The loss compressed 5%. The gross margin is healthy (~67%); the customer-acquisition bill is what consumes it before profit lands.

Renee is not scaling revenue. It is scaling acquisition cost.

The Line That Defines the Year

Advertising and promotion expense was ₹152.41 Cr in FY2025.

Standalone revenue was ₹312.49 Cr. The ratio is 48.8%.

For context, mature beauty companies in India run advertising at 8-15% of revenue. Established global cosmetics players run it at 20-25% during launches and 10-15% in steady state. Renee is at three to five times those levels, which is the trade-off for being five years into category build instead of fifty.

The spend grew 48.7% in FY2025. The revenue line grew 63%. So the ratio is technically improving — slowly. But the absolute increase in advertising (₹50 Cr) almost equals the entire net loss compression target. If the line scales another 40-50% in FY2026, the loss line cannot move.

The hard question is whether the customer acquired in FY2025 will return in FY2026 without another acquisition cost. Cosmetics has structural retention — colour preferences are sticky, refill purchases are recurring, brand loyalty compounds. If Renee's retention curve is strong, the FY2025 ad spend earns back in FY2026 cohort revenue and the operating margin appears. If retention is weak, every new revenue rupee in FY2026 needs another ad rupee, and the model never gets to leverage.

The audit doesn't disclose retention. It only shows the cost of acquisition.

The Gross Margin Protects the Model

The cosmetics category is forgiving in one specific way: gross margins are high.

Cost of materials (₹26 Cr) plus purchases (₹67 Cr) net of inventory build (₹9 Cr) is roughly ₹84 Cr against ₹312 Cr revenue. Implied gross margin: high 60s. ₹209 Cr of gross profit on the standalone P&L.

Subtract ₹37 Cr employees, ~₹98 Cr non-advertising other expenses, ₹5 Cr depreciation, ₹2 Cr finance. That leaves ~₹66 Cr of headroom. The ₹152 Cr advertising line eats all of it, plus another ₹56 Cr that lands as the net loss.

The model works at 35% advertising-to-revenue. It does not work at 49%. That is the entire arithmetic.

The Cash and the Capital

Cash and bank balances fell from ₹90 Cr to ₹68 Cr in FY2025, a drawdown of ₹22 Cr.

That looks moderate until you read the financing line: Renee raised ₹78 Cr in fresh equity during the year. Without that raise, the cash balance would have ended the year at -₹10 Cr.

Each year's burn approximately equals the year's fundraise. This works as long as investors continue to back the model. It stops working the moment the next round is delayed or down-priced.

Without fresh funding, the cash runs out in under a year. ₹68 Cr of cash plus ₹7 Cr current investments against an ₹82 Cr operating burn. Runway: approximately 11 months. Zero debt, no fixed obligations, but also no second source of capital.

Why the Loss Barely Moved

Revenue grew 63%. Loss shrank 5%. There is no operating leverage in the FY2025 P&L.

The reason is structural:

• Variable costs scaled with revenue. Advertising +49%. Logistics, platform fees, payment processing all lifted inside the ₹250 Cr other-expenses line.
• Fixed costs are too small to matter. Employees +19%, depreciation small, finance costs negligible. Total absolute savings: ~₹6 Cr.
• Net effect. Growth pulled variable costs up almost proportionally. The loss compressed only by the small fixed-cost gap.

The fix is not more growth at the same cost ratio. The fix is sub-linear scaling of acquisition cost.

What FY2026 Has to Show

The FY2025 audit makes the FY2026 question precise.

Will the advertising-to-revenue ratio compress? From 48.8% to something nearer 30-35% would put PAT within striking distance of breakeven. From 48.8% staying flat would mean another year of ₹50-60 Cr losses funded by capital.

Will repeat purchase compound? Cosmetics retention compounds quietly: a customer acquired in Year 1 buys again in Year 2 at near-zero acquisition cost. If FY2025's customer base actively repeats in FY2026, revenue grows without proportional ad spend. The audit doesn't disclose this, but it is the single largest variable that determines the trajectory.

Will the next round arrive on terms that don't dilute aggressively? With ~11 months of cash and ₹78 Cr already drawn in FY2025, the company is in market for a Series B+ extension or Series C. The category is in favour with institutional capital today; that may compress.

The model works if these three things land. The model continues funding through capital if they don't.